Doximity, Inc.
DOCS
$43.85
-$0.28-0.63%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 168.53M | 145.91M | 138.29M | 168.60M | 136.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 168.53M | 145.91M | 138.29M | 168.60M | 136.83M |
| Cost of Revenue | 16.43M | 15.79M | 14.47M | 14.18M | 13.68M |
| Gross Profit | 152.10M | 130.12M | 123.82M | 154.42M | 123.16M |
| SG&A Expenses | 56.94M | 48.64M | 50.17M | 51.99M | 44.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.57M | 91.23M | 89.44M | 88.59M | 81.17M |
| Operating Income | 64.96M | 54.69M | 48.85M | 80.02M | 55.67M |
| Income Before Tax | 72.94M | 64.15M | 58.39M | 89.84M | 62.17M |
| Income Tax Expenses | 10.88M | 10.83M | -4.06M | 14.64M | 18.02M |
| Earnings from Continuing Operations | 62.06M | 53.32M | 62.46M | 75.20M | 44.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 62.06M | 53.32M | 62.46M | 75.20M | 44.15M |
| EBIT | 64.96M | 54.69M | 48.85M | 80.02M | 55.67M |
| EBITDA | 66.73M | 55.78M | 50.08M | 81.17M | 56.88M |
| EPS Basic | 0.33 | 0.28 | 0.33 | 0.40 | 0.24 |
| Normalized Basic EPS | 0.25 | 0.21 | 0.19 | 0.30 | 0.22 |
| EPS Diluted | 0.31 | 0.27 | 0.31 | 0.37 | 0.22 |
| Normalized Diluted EPS | 0.23 | 0.20 | 0.18 | 0.28 | 0.20 |
| Average Basic Shares Outstanding | 187.71M | 187.98M | 188.36M | 187.16M | 186.25M |
| Average Diluted Shares Outstanding | 200.75M | 201.16M | 202.99M | 202.23M | 200.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |